This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bailey, J.W. Articles by Miles, J.M. Search for Related Content PubMed PubMed Citation Articles by Bailey, J.W. Articles by Miles, J.M. Social Bookmarking                         What's this?

Triacetin: A Potential Parenteral Nutrient

Endocrine Research Unit, Departments of Medicine and Pediatrics, Mayo Medical School, Rochester, Minnesota

M.W. Haymond, M.D.

Endocrine Research Unit, Departments of Medicine and Pediatrics, Mayo Medical School, Rochester, Minnesota

J.M. Miles, M.D.

Endocrine Research Unit, Departments of Medicine and Pediatrics, Mayo Medical School, Rochester, Minnesota

Triacetin, the water-soluble triglyceride of acetate, was infused in mongrel dogs at isocaloric (N=6) or hypercaloric (~1.5 REE, N =7) rates in mongrel dogs for 3 hr. Ketone body and glucose production rates were quantified with [¹³C₂] acetoacetate and [³H]glucose, respectively. Four additional animals were infused with glycerol to serve as controls for the hypercaloric triacetin infusion. Energy expenditure was determined in the isocaloric experiments. Results: no evidence of acute toxicity was observed during triacetin infusion at either rate. Plasma acetate concentrations increased from basal levels to ~1 and ~13 mmol/liter in the isocaloric and hypercaloric experiments, respectively. Plasma lactate and pyruvate concentrations decreased dramatically after 30 min of both isocaloric and hypercaloric triacetin infusions. Glucose production rates did not increase in either group, but glucose clearance decreased significantly in both groups (p<0.05) over the last hour of triacetin infusion. Plasma ketone body concentrations increased from 1.4 to 3.5 and 1.8 to 13.5 µmol/kg·min, respectively, during isocaloric and hypercaloric triacetin infusion. Resting energy expenditure increased from 3.0 ± 0.3 to 4.0 ± 0.5 kcal/kg·hr during isocaloric triacetin infusion (p<0.05). These studies indicate that triacetin can be administered to dogs at high rates without overt toxicity. The decrease in glucose clearance may represent competition between carbohydrate (glucose) and lipid (acetate). Triacetin infusion resulted in significant increases in ketone body production and concentration. These preliminary data indicate that triacetin may have a future role as a parenteral nutrient, and that further studies of its use are warranted. (Journal of Parenteral and Enteral Nutrition 15: 32-36, 1991)

Journal of Parenteral and Enteral Nutrition, Vol. 15, No. 1, 32-36 (1991)
DOI: 10.1177/014860719101500132


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Mathew, P. Arun, C. N. Madhavarao, J. R. Moffett, and M. A. A. Namboodiri Progress toward Acetate Supplementation Therapy for Canavan Disease: Glyceryl Triacetate Administration Increases Acetate, but Not N-Acetylaspartate, Levels in Brain J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 297 - 303. [Abstract] [Full Text] [PDF]

				Final Report on the Safety Assessment of Triacetin International Journal of Toxicology, June 1, 2003; 22(2_suppl): 1 - 10. [Abstract] [PDF]

				J. W. Lynch, J. M. Miles, and J. W. Bailey Effects of the Short-Chain Triglyceride Triacetin on Intestinal Mucosa and Metabolic Substrates in Rats JPEN J Parenter Enteral Nutr, May 1, 1994; 18(3): 208 - 213. [Abstract] [PDF]